Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.95 USD | +7.72% |
|
+27.85% | -35.23% |
Jul. 01 | Ocuphire Pharma, Inc.(NasdaqCM:OCUP) dropped from Russell Microcap Growth Index | CI |
Jul. 01 | Ocuphire Pharma, Inc.(NasdaqCM:OCUP) dropped from Russell 3000E Growth Index | CI |
Financials (USD)
Sales 2024 * | 7.66M | Sales 2025 * | 65.05M | Capitalization | 46.92M |
---|---|---|---|---|---|
Net income 2024 * | -28M | Net income 2025 * | 43M | EV / Sales 2024 * | 6.13 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.72 x |
P/E ratio 2024 * |
-1.56
x | P/E ratio 2025 * |
1.04
x | Employees | 14 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.59% |
Latest transcript on Ocuphire Pharma, Inc.
1 day | +7.46% | ||
1 week | +27.85% | ||
Current month | +27.43% | ||
1 month | +13.35% | ||
3 months | +5.96% | ||
6 months | -34.90% | ||
Current year | -35.23% |
![Extreme 1.53](/images/extremecours_fleche.png)
![Extreme 1.5](/images/extremecours_fleche.png)
![Extreme 1.5](/images/extremecours_fleche.png)
![Extreme 1.5](/images/extremecours_fleche.png)
![Extreme 1.5](/images/extremecours_fleche.png)
![Extreme 1.5](/images/extremecours_fleche.png)
![Extreme 1.5](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
George Magrath
CEO | Chief Executive Officer | 40 | Oct. 31 |
Nirav Jhaveri
DFI | Director of Finance/CFO | 46 | Feb. 13 |
Barbara Withers
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Rodgers
BRD | Director/Board Member | 57 | 20-10-31 |
James Manuso
BRD | Director/Board Member | 75 | 18-12-31 |
Susan Benton
BRD | Director/Board Member | 59 | 20-10-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-07-12 | 1.95 | +7.72% | 225 163 |
24-07-11 | 1.81 | +9.70% | 179,058 |
24-07-10 | 1.65 | +6.45% | 159,219 |
24-07-09 | 1.55 | -0.64% | 78,000 |
24-07-08 | 1.56 | +2.30% | 78,905 |
Delayed Quote Nasdaq, July 12, 2024 at 03:07 pm EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.23% | 46.92M | |
+62.75% | 841B | |
+40.42% | 625B | |
-4.01% | 360B | |
+17.39% | 327B | |
+10.45% | 300B | |
+15.66% | 242B | |
+17.90% | 227B | |
+15.62% | 174B | |
+0.82% | 162B |
- Stock Market
- Equities
- OCUP Stock